CIBMTR Reporting Implementation Guide
0.1.6 - Trial Use 1

This page is part of the CIBMTR Reporting Implementation Guide (v0.1.6: Release Draft) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example Medication: Medication-PriorExposure-Example

Generated Narrative: Medication

Resource Medication "Medication-PriorExposure-Example"

Profile: CIBMTR Prior Exposure Medication

Security Labels: http://terminology.cibmtr.org/codesystem/transplant-center

code: mogamulizumab (RxNorm#2054068; RxNorm#2054084 "mogamulizumab Injection [Poteligeo]"; RxNorm#2054086 "5 ML mogamulizumab-kpkc 4 MG/ML Injection [Poteligeo]")

Ingredients

-Item[x]Strength
*mogamulizumab (RxNorm#2054068; RxNorm#2054084 "mogamulizumab Injection [Poteligeo]"; RxNorm#2054086 "5 ML mogamulizumab-kpkc 4 MG/ML Injection [Poteligeo]")4 milligram (Details: UCUM code mg = 'mg')/0.035 milliliter (Details: UCUM code mL = 'mL')